Open-label Clinical Trial to Investigate the Safety and Tolerability of Allogeneic B-cell Concentrates for Immune Reconstitution After Allogeneic Stem Cell Transplantation Measured as Response to a Antedated Single Vaccination

NCT02007811 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Acute Myeloid Leukemia
Acute Lymphoblastic Leukemia
Chronic Myeloid Leukemia
Non Hodgkin's Lymphoma
Hodgkin's Disease
Myelodysplastic Syndrome
Multiple Myeloma
Aplastic Anemia

Interventions

BIOLOGICAL: allogeneic donor derived B-lymphocytes

Sponsor

University of Erlangen-Nürnberg Medical School

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]